Centro Hospitalar Cova da Beira, E.P.E.

Covilha 6200-502

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Ischemic Stroke; Ischemic Attack, Transient

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) — Stopped early